New options for teen pregnancy prevention

MCN The American Journal of Maternal/Child Nursing

Volumn 29, Issue 1, 2004, Pages 30-35

  Kartoz, Connie R ^a,b,c  

^a HiTOPS Inc   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c c/o HiTops ^*  (United States)

Author keywords

Adolescents; Contraception; Emergency Contraception; NuvaRing

Indexed keywords

CONTRACEPTIVE AGENT; ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; ETHINYLESTRADIOL PLUS ETONOGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; ORTHOEVRA; SEASONALE; UNCLASSIFIED DRUG;

ADOLESCENT PREGNANCY; ALLERGIC REACTION; CANCER RISK; CLINICAL TRIAL; CONDOM; CONTRACEPTION; DRUG CONTRAINDICATION; DRUG EFFICACY; HEADACHE; HEALTH EDUCATION; HUMAN; MENSTRUAL IRREGULARITY; NURSE; PRIVACY; REVIEW; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SKIN MANIFESTATION; SPOTTING; UNITED STATES; VAGINA SECRETION; WEIGHT GAIN; ADOLESCENT; FEMALE; MATERNAL CARE; METHODOLOGY; NURSING; PREGNANCY; SEXUAL BEHAVIOR; SEXUAL EDUCATION;

ADOLESCENT; CONTRACEPTION; CONTRACEPTION BEHAVIOR; FEMALE; HUMANS; MATERNAL-CHILD NURSING; PREGNANCY; PREGNANCY IN ADOLESCENCE; SEX EDUCATION;

EID: 2142828160     PISSN: 0361929X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005721-200401000-00009     Document Type: Review

References (29)

1. American Academy of Pediatrics Committee on Adolescence. (2001). Condom Use By Adolescents. Pediatrics, 107(6), 1463-1469.
2. American Cancer Society. (2002). What are the Risk Factors for Cervical Cancer. Retrieved September 15, 2003, from www.cancer.org./doc-root/CRI/content/ CRI_2_4_2X_what_are_the_risk_factors_for_cervical_ cancer 8.asp.
3. Anderson, F. D., & Hait, H. (2003). A multicenter, randomized study of an extended cycle oral contraceptive. Contraception, 68(2), 89-96.
4. Archer, D. F., Bigrigg, A., Smallwood, G. H., Shanghold, G. A., Creasy, G. W., & Fisher, A. C. (2002). Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. Fertility and Sterility, 77(Suppl 2), S27-S31.
5. Audet, M. C., Moreau, M., Koltun, W. D., Waldbaum, A. A., Shangold, G., Fisher, A. C., et al. for the ORTHO EVRA/EVRA 004 Study Group (2001). Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. Journal of the American Medical Association, 285, 2347-2354.
6. Barr Pharmaceuticals. (2003). Seasonale: Prescribers Information. Retrieved September 15, 2003, from www.seasonale.com/product_info/prescribing. asp.
7. Center for Disease Control. (2002). Teen Pregnancy. Retrieved September 15, 2003, from http://www.cdc.gov/nccdphp/teen.htm.
8. Darroch, J. E., Singh, S., & Frost, J. J. (2001). Differences in teenage pregnancy rates among five developed countries: The roles of sexual activity and contraceptive use. Family Planning Perspectives, 33(6), 244-250.
9. Department of Health and Human Services (DHHS). (2002a). Preventing Teenage Pregnancy. Retrieved September 15, 2003, from http://www.hhs.gov/news/ press/2002pres/teenpreg.html.
10. Department of Health and Human Services (DHHS). (2002b). Healthy People, 2010. Retrieved September 15, 2003, from http://www.healthy-people.gov/Documen1/ HTML/Volume1/09Family.htm.
11. Food and Drug Administration (FDA). (2003). Pharmacia Corporation announces voluntary recall of Lunelle. Retrieved September 22, 2003 from www.fda.gov/oc/po/firmrecalls/pharmacia10_02.html.
12. Grimes, D. (Ed.) (2002). Suppression of menstruation with extended OC regimens. The Contraceptive Report, 13(3), 8-11.
13. Guttmacher Institute. (2002a). Teenagers sexual and reproductive health. Retrieved September 15, 2003, from http://www.agi-usa.org/pubs/fb_teens.html.
14. Guttmacher Institute (2002b). Into a new world: Young Women's sexual and reproductive lives. Retrieved September 15, 2003, from http://www.guttmacher. org/pubs/new_world_engl.html.
15. Lindberg, C. (2003). Emergency contraception for prevention of adolescent pregnancy. MCN, The American Journal of Maternal Child Nursing, 28(3), 199-204.
16. Mulders, T. M., & Dieben, T. O. (2001). Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. Fertility and Sterility, 75(5), 865-870.
17. Muram, D. (1994). Pediatric and Adolescent Gynecology. In A. H. DeCherney & M. L. Pernoll (Eds.), Current Obstetric and Gynecological Diagnosis and Treatment (pp. 633-669). Norwalk, CT: Appleton & Lange.
18. National Association of Nurse Practitioners in Women's Health (NAN-PWH). (2002). Weight, sexuality and women's birth control decisions. Retrieved September 15, 2003, from http://www.npwh.org/executive_summary.htm.
19. Organon Pharmaceutical. (2002). NuvaRing: The vaginal birth control ring. Retrieved September 15, 2003, from http://www.nuvaring.com/index.html.
20. Ortho-McNeal Pharmaceutical. (2002). Ortho Evra: The new contraceptive patch. Retrieved September 15, 2003, from http://www.orthoevra.com/index.html.
21. Planned Parenthood. (2002). America's Family Planning Program: Title X. Retrieved September 15, 2003, from http://www.plannedparenthood.org/library/ FAMILYPLANNINGISSUES/TitleX_fact.html.
22. Reddy, D. A., Fleming, R., & Swain, C. (2002). Effect of mandatory parental notification on adolescent girls' use of sexual health care services. Journal of the American Medical Association, 288, 710-716.
23. Rodrigues, I., Grou, I., & Joly, J. (2001). Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected intercourse. American Journal of Obstetrics and Gynecology, 184(4), 531-537.
24. Rosenberg, M. J., Waugh, M. S., & Meehan, T. E. (1995). Use and misuse of oral contraceptives: Risk indicators for poor pill taking and discontinuation. Contraception, 51, 283-288.
25. Roumen, F. J., Apter, D., Mulders, T. M., & Dieben, T. O. (2001). Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Human Reproduction, 16(3), 469-475.
26. Stewart, G. (1998). Intrauterine devices. In R. A. Hatcher, ed. Contraceptive Technology (17th ed). New York: Ardent Media Inc.
27. Wilson, K. W., & Klein, J. D. (2002). Health care and contraceptive use among adolescents reporting unwanted sexual intercourse. Archives of Pediatrics and Adolescent Medicine, 156(4), 341-344.
28. Wysocki, S., & Moore, A (2002). New developments in contraception: The first transdermal contraceptive system. National Association of Nurse Practitioners in Women's Health. Retrieved September 15, 2003, from http://www.npwh.org/CE-Transdermal/index.html.
29. Zieman M., Guillebaud J., Weisberg E., Shangold, G. A., Fisher, A. C., & Creasy, G. W. (2002). Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: The analysis of pooled data. Fertility and Sterility, 77(2 [Suppl 2]), S13-S18.